Production (Stage)
Harmony Biosciences Holdings, Inc.
HRMY
$35.14
-$0.71-1.98%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 152.72M | 145.49M | 122.63M | 114.99M | 137.70M |
| Total Depreciation and Amortization | 23.96M | 24.11M | 24.27M | 24.41M | 24.42M |
| Total Amortization of Deferred Charges | 686.00K | 700.00K | 716.00K | 1.79M | 2.04M |
| Total Other Non-Cash Items | 58.16M | 56.84M | 64.81M | 68.80M | 32.84M |
| Change in Net Operating Assets | -12.86M | -7.32M | 8.51M | 3.53M | 10.97M |
| Cash from Operations | 222.67M | 219.82M | 220.92M | 213.52M | 207.97M |
| Capital Expenditure | -1.28M | -1.15M | -747.00K | -744.00K | -317.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -33.07M | -33.07M | -70.04M | -70.04M | -36.97M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.59M | -33.26M | -25.58M | -27.14M | -13.55M |
| Cash from Investing | -58.94M | -67.48M | -96.36M | -97.92M | -50.84M |
| Total Debt Issued | -- | -- | 0.00 | 200.00M | 200.00M |
| Total Debt Repaid | -15.00M | -15.00M | -15.00M | -207.75M | -204.50M |
| Issuance of Common Stock | 11.09M | 6.50M | 3.49M | 1.16M | 1.26M |
| Repurchase of Common Stock | -3.81M | -2.50M | -50.27M | -100.27M | -100.51M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -8.84M | -8.84M |
| Cash from Financing | -7.71M | -11.00M | -61.78M | -115.70M | -112.60M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 156.02M | 141.34M | 62.78M | -99.00K | 44.54M |